Spruce Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-47.92	-46.18	-42.29	-29.54	-13.09	-9.86
Depreciation & Amortization	0.3	0.43	0.38	0.1	0.01	0
Share-Based Compensation	4.62	3.63	3.96	0.76	0.2	0.1
Other Operating Activities	9.72	0.44	2.08	1.16	0.26	1.19
Operating Cash Flow	-33.28	-41.68	-35.88	-27.52	-12.62	-8.57
Capital Expenditures	-0.01	-0.01	-0.09	-0.07	-0	0
Change in Investments	55.78	23.7	-79.08	0	0	0
Investing Cash Flow	55.78	23.69	-79.17	-0.07	-0	0
Share Issuance / Repurchase	53.79	0.08	0.46	93.4	0	0
Debt Issued / Paid	-1.62	0	0.22	0	4.49	0
Other Financing Activities	-3.02	-0.32	-0.04	87.63	7.94	-
Financing Cash Flow	49.14	-0.24	0.64	181.04	12.43	0
Net Cash Flow	71.64	-18.23	-114.4	153.44	-0.19	-8.57
Free Cash Flow	-33.28	-41.69	-35.97	-27.59	-12.62	-8.57
Free Cash Flow Margin	-329.88%	-	-	-	-	-
Free Cash Flow Per Share	-0.86	-1.77	-1.54	-4.61	-16.51	-1.74

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).